Raamovereenkomst voor de levering van elektriciteit en het afsluiten van injectiecontracten 2029-2030
Belgium · Diepenbeek · how to bid here →
Your path to submission
- Deadline: 14 September at 00:00 — 4 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: NLD, NLD, NLD.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- The median procedure drew 5 bids (127 procedures with a bid count); 2% ended with a single bidder. Sector: median 2 bids.n = 127
- 21% of this buyer's awards went to companies that had already won here before (228 awards since 2015, spread over 136 companies). That is well above the sector norm (8%) — newcomers have a harder time here than elsewhere.n = 228 awards since 2015
- 29% of awards went to companies from abroad (228 awards with a known winner country). Sector average: 21%.n = 228
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 09/09/2026.
Foreign bidders
In Belgium · Petroleum & fuels, 79 contracts went to foreign companies over the last 3 years (of 423 recorded awards) — mostly from France, Netherlands, Germany.
Typical field: median 3 (from 150 awards).
What the buyer is looking for
HospiLim wenst een raamovereenkomst af te sluiten voor de levering van elektriciteit in hoogspanning en het afsluiten van injectiecontracten voor de leveringsjaren 2029 en 2030 aan haar eigen leden alsook aan de leden van Integro vzw en Ocura vzw.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in NLD, NLD, NLD.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| DUOMED BELGIUM | 5 | 2025–2026 |
| Fresenius Kabi NV | 4 | 2024 |
| Medica Europe B.V. | 4 | 2025–2026 |
| MOLNLYCKE HEALTH CARE | 4 | 2025–2026 |
| Arega Pharma BV | 4 | 2022–2024 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.